China Nepstar Chain Drugstore Announces New Management Te...( SHENZHEN China Jan. 5 Asia-FirstC...),Health

SHENZHEN, China, Jan. 5 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced the appointment of Mr. Ian Wade, a retail industry veteran with an outstanding track record of success, as the Co-Chief Executive Officer. Concurrently, the Company announced the appointment of Mr. William Weili Dai as the new Chief Financial Officer. Both appointments will be effective on January 5, 2009.

Formally with AS Watson as the Group Managing Director for 25 years, Mr. Ian Wade managed one of the world's largest and fastest growing global retail companies, with over 7,700 stores in 37 countries. During his tenure at AS Watson, he turned the Hong Kong based business, which then had 16 stores, into a highly profitable, international retail chain with extensive reach throughout Asia and Europe. Under his leadership, Watson opened 270 stores in mainland China and 400 stores in Taiwan, and launched groundbreaking hypermarkets in mainland China. In addition, Mr. Wade also managed Watson's retail operations and private label businesses in many countries in Europe.

Mr. William Weili Dai brings to Nepstar over 15 years of experience in financial management and accounting. Prior to joining Nepstar, Mr. Dai was the chief financial officer of MicroPort Medical, a leading medical device company in China. From 1996 to 2006, Mr. Dai served as finance manager in charge of China operations for three leading global companies, Mundipharma Pharmaceuticals, Boston Scientific and Case Corporation. During his tenure at Mundipharma and Boston Scientific, he was involved in multiple strategic M&A and business development projects in China. Mr. Dai began his financial management career
'/>"/>